{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:19:42Z","timestamp":1793513982379,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejase.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Echocardiography"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.echo.2025.05.013","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T20:45:51Z","timestamp":1748637951000},"page":"775-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Echocardiographic Evaluation of Carcinoid Heart Disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Chadi","family":"Ayoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6459-9767","authenticated-orcid":false,"given":"Isabel G.","family":"Scalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Allen","family":"Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Crestanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Mauermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorvardur R.","family":"Halfdanarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Pellikka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.echo.2025.05.013_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13146","article-title":"European neuroendocrine tumor society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease","volume":"34","author":"Grozinsky-Glasberg","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.echo.2025.05.013_bib2","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/S0140-6736(24)00701-3","volume":"403","author":"Singh","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.echo.2025.05.013_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1067\/j.cpradiol.2022.11.011","article-title":"Gastroenteropancreatic neuroendocrine tumor metastasis to the heart: evaluation of imaging manifestations","volume":"52","author":"Wang","year":"2023","journal-title":"Curr Probl Diagn Radiol"},{"key":"10.1016\/j.echo.2025.05.013_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pcad.2006.12.002","article-title":"Carcinoid heart disease","volume":"49","author":"Bernheim","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.echo.2025.05.013_bib5","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jtho.2018.06.023","article-title":"Carcinoid heart disease in patients with bronchopulmonary carcinoid","volume":"13","author":"De Jesus","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.echo.2025.05.013_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000461583","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pre- and perioperative therapy in patients with neuroendocrine tumors","volume":"105","author":"Kaltsas","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.echo.2025.05.013_bib7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/hrt.2004.040329","article-title":"Carcinoid heart disease: presentation, diagnosis, and management","volume":"90","author":"Fox","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.echo.2025.05.013_bib8","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement","volume":"69","author":"Davar","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2025.05.013_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.beem.2015.09.005","article-title":"Carcinoid heart disease: diagnosis and management","volume":"30","author":"Luis","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.echo.2025.05.013_bib10","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.jcmg.2020.12.030","article-title":"Cardiac imaging in carcinoid heart disease","volume":"14","author":"Baron","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2025.05.013_bib11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2025.05.013_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/endrev\/bnad035","article-title":"What is carcinoid syndrome? A critical appraisal of its proposed mediators","volume":"45","author":"Mulders","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/j.echo.2025.05.013_bib13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","article-title":"Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography","volume":"92","author":"Robiolio","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2025.05.013_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MPA.0b013e318271c0d5","article-title":"A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs)","volume":"42","author":"Tellez","year":"2013","journal-title":"Pancreas"},{"key":"10.1016\/j.echo.2025.05.013_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ejendo\/lvae150","article-title":"Serum and urinary 5-hydroxyindolacetic acid, serotonin, chromogranin A, and NT-proBNP for the detection of carcinoid heart disease","volume":"191","author":"Lecoeur","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.echo.2025.05.013_bib16","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.echo.2025.05.013_bib17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing but NET: a review of neuroendocrine tumors and carcinomas","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.echo.2025.05.013_bib18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(17)30110-9","article-title":"Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study","volume":"18","author":"Halperin","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.echo.2025.05.013_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0025-6196(11)62328-8","article-title":"Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years","volume":"77","author":"Simula","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.echo.2025.05.013_bib20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2025.05.013_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000381930","article-title":"Carcinoid heart disease: from pathophysiology to Treatment--'Something in the way it moves'","volume":"101","author":"Grozinsky-Glasberg","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.echo.2025.05.013_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000507847","article-title":"Carcinoid heart disease: pathophysiology, pathology, clinical manifestations, and management","volume":"146","author":"Jin","year":"2021","journal-title":"Cardiology"},{"key":"10.1016\/j.echo.2025.05.013_bib23","first-page":"400","article-title":"Circulating plasma and platelet 5-hydroxytryptamine in carcinoid heart disease: a pilot study","volume":"22","author":"Bhattacharyya","year":"2013","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.echo.2025.05.013_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103959","article-title":"Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers","volume":"9","author":"Algeri","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.echo.2025.05.013_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jtcvs.2018.09.025","article-title":"Improving outcome of valve replacement for carcinoid heart disease","volume":"158","author":"Nguyen","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.echo.2025.05.013_bib26","article-title":"Detection of cardiac neuroendocrine tumour metastases by somatostatin receptor PET\/CT: a systematic review and meta-analysis","volume":"11","author":"Campanale","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.echo.2025.05.013_bib27","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2967\/jnumed.124.267948","article-title":"Cardiac neuroendocrine tumor metastases on (68)Ga-DOTATATE PET\/CT: identification and prognostic significance","volume":"65","author":"Lee","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.echo.2025.05.013_bib28","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jaccao.2024.09.008","article-title":"Lutetium-177 DOTATATE therapy and cardiac outcomes in patients with neuroendocrine tumor and cardiac metastases","volume":"6","author":"Scalia","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.echo.2025.05.013_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16233896","article-title":"The value of repeat 5-HIAA measurements as a predictor of carcinoid heart disease: a prospective 5-year follow-up study in patients with small intestinal neuroendocrine tumors","volume":"16","author":"Kostiainen","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.echo.2025.05.013_bib30","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjcard.2008.05.047","article-title":"Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease","volume":"102","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2025.05.013_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13323","article-title":"Patent foramen ovale in carcinoid heart disease: the potential role for and risks of percutaneous closure prior to cardiothoracic surgery","volume":"35","author":"Douglas","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.echo.2025.05.013_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.02.019","article-title":"Assessment of patent foramen ovale in carcinoid heart disease","volume":"151","author":"Mansencal","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.echo.2025.05.013_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13060","article-title":"Synoptic reporting of echocardiography in carcinoid heart disease (ENETS carcinoid heart disease task force)","volume":"34","author":"Hofland","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.echo.2025.05.013_bib35","doi-asserted-by":"crossref","first-page":"e005332","DOI":"10.1161\/CIRCIMAGING.116.005332","article-title":"State-of-the-Art review of echocardiographic imaging in the evaluation and treatment of functional tricuspid regurgitation","volume":"9","author":"Hahn","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2025.05.013_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCIMAGING.109.886846","article-title":"Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI","volume":"3","author":"Bhattacharyya","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2025.05.013_bib37","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0735-1097(98)00354-4","article-title":"Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease","volume":"32","author":"Denney","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2025.05.013_bib38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.0007-1323.2001.01798.x","article-title":"Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome","volume":"88","author":"Westberg","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.echo.2025.05.013_bib39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.amjcard.2007.08.045","article-title":"Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century","volume":"101","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2025.05.013_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000360767","article-title":"Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease","volume":"99","author":"Dobson","year":"2014","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.echo.2025.05.013_bib41","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.amjcard.2010.01.017","article-title":"Echocardiographic follow-up of treated patients with carcinoid syndrome","volume":"105","author":"Mansencal","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2025.05.013_bib42","doi-asserted-by":"crossref","first-page":"G19","DOI":"10.1530\/ERP-19-0051","article-title":"Echocardiographic assessment of the right heart in adults: a practical guideline from the British Society of Echocardiography","volume":"7","author":"Zaidi","year":"2020","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.echo.2025.05.013_bib43","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.echo.2015.05.015","article-title":"Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the American society of echocardiography and society for cardiac angiography and interventions","volume":"28","author":"Silvestry","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib44","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib46","article-title":"Echocardiographic evaluation of the right atrial size and function: relevance for clinical practice","volume":"27","author":"Sun","year":"2023","journal-title":"Am Heart J Plus"},{"key":"10.1016\/j.echo.2025.05.013_bib47","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ehjci\/jeae182","article-title":"Right atrial and right ventricular strain: prognostic value depends on the severity of tricuspid regurgitation","volume":"25","author":"Curtis","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2025.05.013_bib48","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcmg.2022.06.022","article-title":"Normal ranges of right atrial strain: a systematic review and meta-analysis","volume":"16","author":"Krittanawong","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2025.05.013_bib49","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.echo.2024.06.004","article-title":"Right atrial and ventricular strain analysis in patients with carcinoid heart disease","volume":"37","author":"Alabdaljabar","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib51","first-page":"24","article-title":"Visibility of pulmonary valve and pulmonary regurgitation on intracardiac echocardiography in adult patients with tetralogy of Fallot","volume":"10","author":"Sakamoto","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.echo.2025.05.013_bib52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ejechocard\/jeq030","article-title":"European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease)","volume":"11","author":"Lancellotti","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib53","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3390\/cancers15061875","article-title":"The role of transthoracic echocardiography for assessment of mortality in patients with carcinoid heart disease undergoing valve replacement","volume":"15","author":"Brooke","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.echo.2025.05.013_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.echo.2025.01.006","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults and special considerations in pulmonary hypertension: recommendations from the American society of echocardiography","volume":"38","author":"Mukherjee","year":"2025","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib55","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCIMAGING.113.000640","article-title":"Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension","volume":"6","author":"Fine","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2025.05.013_bib56","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/ehjci\/jeac022","article-title":"Right ventricular longitudinal strain in the clinical routine: a state-of-the-art review","volume":"23","author":"Muraru","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2025.05.013_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000431076","article-title":"Myocardial function by two-dimensional speckle tracking echocardiography and activin A may predict mortality in patients with carcinoid intestinal disease","volume":"132","author":"Zahid","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.echo.2025.05.013_bib58","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.echo.2011.02.009","article-title":"Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease","volume":"24","author":"Haugaa","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.698158","article-title":"The predictive value of right ventricular longitudinal strain in pulmonary hypertension, heart failure, and valvular diseases","volume":"8","author":"Tadic","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.echo.2025.05.013_bib60","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10741-023-10329-y","article-title":"The prognostic value of right ventricular longitudinal strain in heart failure: a systematic review and meta-analysis","volume":"28","author":"Anastasiou","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.echo.2025.05.013_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001060","article-title":"Multimodality imaging in carcinoid heart disease","volume":"6","author":"Agha","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.echo.2025.05.013_bib62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jcct.2020.08.009","article-title":"Features of carcinoid heart disease identified by cardiac computed tomography","volume":"15","author":"Davar","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.echo.2025.05.013_bib63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.amjcard.2023.03.014","article-title":"Impact of atrial fibrillation on patients with carcinoid syndrome: a national inpatient sample analysis","volume":"196","author":"Babbili","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2025.05.013_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14503\/THIJ-17-6562","article-title":"Carcinoid heart disease: review of current knowledge","volume":"46","author":"Ram","year":"2019","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.echo.2025.05.013_bib65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jacep.2020.08.009","article-title":"Catheter ablation in patients with neuroendocrine (carcinoid) tumors and carcinoid heart disease: outcomes, peri-procedural complications, and management strategies","volume":"7","author":"Shabtaie","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.echo.2025.05.013_bib66","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","article-title":"Outcome of cardiac surgery for carcinoid heart disease","volume":"25","author":"Connolly","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2025.05.013_bib67","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.hrthm.2021.08.021","article-title":"Outcomes and periprocedural management of cardiac implantable electronic devices in patients with carcinoid heart disease","volume":"18","author":"Ward","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.echo.2025.05.013_bib68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.14740\/cr986","article-title":"Incidence of atrioventricular block after valve replacement in carcinoid heart disease","volume":"11","author":"Sunjic","year":"2020","journal-title":"Cardiol Res"},{"key":"10.1016\/j.echo.2025.05.013_bib69","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s10840-024-01796-w","article-title":"Leadless pacemaker implantation following tricuspid interventions: multicenter collaboration of feasibility and safety","volume":"67","author":"Gul","year":"2024","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.echo.2025.05.013_bib70","doi-asserted-by":"crossref","first-page":"359","DOI":"10.31083\/j.rcm2510359","article-title":"Comparison of postoperative outcomes between leadless and conventional transvenous pacemakers implantation: an up-to-date meta-analysis","volume":"25","author":"Dai","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.echo.2025.05.013_bib71","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11936-013-0265-2","article-title":"Carcinoid valve disease","volume":"15","author":"Askew","year":"2013","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.echo.2025.05.013_bib72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/jc.2015-3295","article-title":"Effect of valvular surgery in carcinoid heart disease: an observational cohort study","volume":"101","author":"Edwards","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.echo.2025.05.013_bib73","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jacc.2015.09.014","article-title":"Early and late outcomes of surgical treatment in carcinoid heart disease","volume":"66","author":"Connolly","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2025.05.013_bib74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.surg.2021.02.054","article-title":"Outcomes of surgical treatment for carcinoid heart disease: a systematic review and meta-analysis","volume":"170","author":"O'Malley","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.echo.2025.05.013_bib75","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2025.05.013_bib76","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jocs.15169","article-title":"Surgical aspects of valve replacement in carcinoid heart disease","volume":"36","author":"Albage","year":"2021","journal-title":"J Card Surg"},{"key":"10.1016\/j.echo.2025.05.013_bib77","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of cardiology\/American heart association task force on practice guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.echo.2025.05.013_bib78","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s11864-022-01023-6","article-title":"Current practice in carcinoid heart disease and burgeoning opportunities","volume":"23","author":"Lenneman","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.echo.2025.05.013_bib79","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1245\/s10434-022-11371-0","article-title":"Shifting paradigms in the pathophysiology and treatment of carcinoid crisis","volume":"29","author":"Maxwell","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.echo.2025.05.013_bib80","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1245\/s10434-023-14876-4","article-title":"Comparison of octreotide and vasopressors as first-line treatment for intraoperative carcinoid crisis","volume":"31","author":"McCully","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.echo.2025.05.013_bib81","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.surg.2021.03.063","article-title":"A prospective study of carcinoid crisis with no perioperative octreotide","volume":"171","author":"Wonn","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.echo.2025.05.013_bib82","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1245\/s10434-024-15264-2","article-title":"Comparison of octreotide and vasopressors as first-line treatment for intraoperative carcinoid crisis","volume":"31","author":"Ammann","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.echo.2025.05.013_bib83","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11886-019-1207-8","article-title":"Carcinoid heart disease: a comprehensive review","volume":"21","author":"Hassan","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.echo.2025.05.013_bib84","first-page":"110","article-title":"Carcinoid heart valve disease: transcatheter pulmonary valve-in-valve implantation in failing biological xenografts","volume":"24","author":"Conradi","year":"2015","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.echo.2025.05.013_bib85","article-title":"Percutaneous transcatheter pulmonary and tricuspid valve replacements in a patient with carcinoid heart disease","volume":"7","author":"Pereyra","year":"2023","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.echo.2025.05.013_bib86","article-title":"Bioprosthetic aortic valve degeneration after TAVR and SAVR: incidence, diagnosis, predictors, and management","volume":"11","author":"Bismee","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.echo.2025.05.013_bib87","series-title":"Reinterventions following cardiac surgery in patients with carcinoid heart disease","author":"Zheng","year":"2025"},{"key":"10.1016\/j.echo.2025.05.013_bib88","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s11886-022-01739-9","article-title":"Tricuspid valve percutaneous therapies","volume":"24","author":"Bhardwaj","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.echo.2025.05.013_bib89","doi-asserted-by":"crossref","first-page":"e1223","DOI":"10.1161\/CIR.0000000000001232","article-title":"The tricuspid valve: a review of pathology, imaging, and current treatment options: a scientific statement from the American heart association","volume":"149","author":"Davidson","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2025.05.013_bib90","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2018.04.031","article-title":"Transcatheter tricuspid valve interventions: landscape, challenges, and future directions","volume":"71","author":"Asmarats","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2025.05.013_bib91","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/1573403X15666181224113855","article-title":"Percutaneous pulmonary valve implantation: current status and future perspectives","volume":"15","author":"Driesen","year":"2019","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.echo.2025.05.013_bib92","first-page":"e698","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Stout","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2025.05.013_bib93","doi-asserted-by":"crossref","first-page":"R184","DOI":"10.1530\/EC-19-0413","article-title":"Multidisciplinary team management of carcinoid heart disease","volume":"8","author":"Steeds","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.echo.2025.05.013_bib94","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.echo.2013.07.009","article-title":"Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists","volume":"26","author":"Hahn","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib95","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.echo.2023.10.004","volume":"37","author":"Zoghbi","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaccas.2019.11.037","article-title":"A rare case of carcinoid constrictive pericarditis","volume":"2","author":"Wang","year":"2020","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.echo.2025.05.013_bib97","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/hrt.82.5.641","article-title":"Carcinoid constrictive pericarditis","volume":"82","author":"Johnston","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.echo.2025.05.013_bib98","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/heartjnl-2013-304070","article-title":"Mechanism of septal bounce in constrictive pericarditis: a simultaneous cardiac catheterisation and echocardiographic study","volume":"99","author":"Coylewright","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.echo.2025.05.013_bib99","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/ejechocard\/jen258","article-title":"Using mitral 'annulus reversus' to diagnose constrictive pericarditis","volume":"10","author":"Reuss","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.echo.2025.05.013_bib100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCIMAGING.113.001613","article-title":"Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria","volume":"7","author":"Welch","year":"2014","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Journal of the American Society of Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0894731725002731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0894731725002731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:55:26Z","timestamp":1756900526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0894731725002731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":100,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0894731725002731"],"URL":"https:\/\/doi.org\/10.1016\/j.echo.2025.05.013","relation":{},"ISSN":["0894-7317"],"issn-type":[{"value":"0894-7317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Echocardiographic Evaluation of Carcinoid Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Echocardiography","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.echo.2025.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"2025 The Authors. Published by Elsevier Inc. on behalf of the American Society of Echocardiography.","name":"copyright","label":"Copyright"}]}}